Nunes Anne

Nunes Anne is listed in filings as SVP at Anika Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 18, 2025, including 10 public disclosures. Recent filings connect the profile to Anika Therapeutics, Inc. (ANIK). The current snapshot covers public activity from Oct 4, 2024 to Mar 18, 2025. Reported amounts are shown as $17.0K to $15.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.